CRST – Clinical trials with 30 years of experience https://validator.w3.org/feed/docs/rss2.html Management team footer Contact us Lihavuuden hoidossa kohti mullistusta CRST has appointed Petri Vainio as the CRST’s new Chief Scientific Officer CRST participated in the CTAD conference in San Francisco Scientific publications News Our research units Why CRST? PHASE I LINK Medical AS acquires Finnish clinical research service company CRST Oy. An interview with CRST’s Key Account Manager Tavoitteena uudenlainen lääke Parkinsonin taudin hoitoon Customer’s story – Avilex Pharma CRST is conducting a clinical study of a new drug for Alzheimer’s Disease in Turku and Helsinki CRST and Kancera AB signed a contract for a First-in-human trial with KAND145 Join CRST Team Customer Relations Customer’s story – Herantis Pharma CRST:n ja Turun PET -keskuksen yhteistyö Lihavuuden lääkehoidossa kohti mullistusta CRST’s scientific team contributed in a study evaluating an ASO in mild Alzheimer’s disease Invesdor_fi Researcher of the Year 2022 Quality Invest in CRST Invesdor About Services CRST collaborates with the local Alzheimer associations Study subject recruitment Header Etusivu